Advertise on podcast: Good Value | Pragmatic Value Investing

In the final episode of of 2025 on Antipodes podcast, our sector portfolio managers were tasked with sharing their highest-conviction ideas for the year ahead. Key times: 1:00 | Graham Hay - Industrials (Honeywell International Inc) 8:30 | Nick Cameron - Healthcare (Merck & Co Inc) 17:30 | Max Shramchenko - Infrastructure (Companhia de Saneamento Básico do Estado de São Paulo) 26:30 | James Rodda - Technology (Oracle Corp) 35:00 | John Stavliotis - Emerging Markets (Globant SA)

Antipodes Investment Director, Alison Savas, is joined by Antipodes Global SMID Portfolio Manager, James Rodda, for a discussion about some of the key opportunities in global small and mid-cap equities (Global SMIDs).  Stock commentary is illustrative only. Not a recommendation to buy, hold, or sell any security. Past performance is not reliably indicative of future performance. A Key times: Intro to the global small and mid-cap sector: 1:30 Managing risk in global SMIDs: 7:30 The macro backdrop for global SMIDs: 10:00 Why industry research is so important in global SMIDs: 13:30 Key performance drivers for the Antipodes Global SMID Fund: 18:30 Investing in global small and mid-cap stocks in the energy sector: 20:00 James' pick for the most under-appreciated SMID stock in Antipodes' portfolio: 26:30

A bonus audio version of our Q3 2025 market and portfolio positioning update.

The US economy remains remarkably strong — but beneath the surface, a two-speed story is emerging. In this episode, Alison Savas is joined by Portfolio Manager Vihari Ross to unpack what’s driving US resilience, from fiscal scaffolding supporting consumption to the AI investment boom reshaping corporate earnings. They also discuss where Antipodes is finding value in today's market. Can the good times keep rolling in the US: 1:00 How critical is fiscal stimulus to US exceptionalism: 5:20 Can AI capex offset any weakness in consumption: 8:50 A stock that could be one of the largest gainers in incremental AI spend: 12:50 Daikin Industries (6367.T) - both cyclical and structural opportunities: 16:40 How we would respond if the US starts to deteriorate: 19:15

Antipodes investment director, Alison Savas, is joined by Ian Harnett, founder of Absolute Strategy Research. Key times: Breaking down US job market data: 1:10 Do Tariffs matter? 6:30 How enduring can the current market resilience be? 10:30 Is the AI trade in a bubble? 12:00 Emerging Markets, Europe and valuations outside the US: 21:00 Risks in markets heading in 2026: 24:10 What could surprise on the upside in 2026: 25:50 Ian’s biggest investing lessons: 28:00

In this episode, Alison Savas is joined by Pinnacle Investment Management Group's Chief Investment Strategist, Anthony Doyle.  Anthony shares perspectives on asset allocation, and they delve into one of the biggest debates in the world of investing - active vs passive.  Key times: Active vs passive investing: 1:00 Current asset allocation trends: 6:40 How behavioural biases can set investors back: 10:00 Building resilience and diversification into protfolios: 12:00 Defining value: 18:00 Avoid market traps 22:30 How should your teenagers invest? 27:50 Content in this podcast should not be considered to be investment advice. It is general information only which doesn't consider your personal financial situation, objectives, or needs. Stock commentary should not be considered as recommedations to buy, hold, or sell any security. Seek professional advice before making investing decisions.

A bonus audio version of our Q2 2025 market and portfolio positioning update.

Investment Director Alison Savas and Portfolio Manager Graham Hay discuss US fiscal sustainability, what the equity and bond markets are signalling, and how Antipodes is positioning portfolios in the current landscape.

Alison Savas interviews James Rodda, Lead Portfolio Manager of the Antipodes Global SMIDs Fund, to explore why global small and mid-cap stocks (SMIDs) present powerful, under-appreciated alpha opportunities. They unpack the valuation gap between SMIDs and large caps, and how Antipodes’ strong investment platform and industry-led research approach provides a unique edge in identifying mis-priced opportunities. A must-listen for anyone considering allocating to global SMIDs. Key times: Why Antipodes launched a global SMIDs Fund: 0:45 Why investors should consider an allocation to global SMIDs: 3:00 The importance of industry-led research & discussion about investing in Roku Inc (NASDAQ: ROKU): 08:00 Antipodes gobal SMID Fund performance: 18:00 Why Brookdale Senior Living Inc (NYSE: BKD) is one of the Fund's largest positions: 24:50 Stock commentary is illustrative only. Not recommendations to buy, hold, or sell any security.

Antipodes Emerging Markets Portfolio Manager, John Stavliotis, shares insights from a recent research trip to China, and discusses some of the Antipodes team's best investment ideas.

This episode features Antipodes Investment Director, Alison Savas, and Antipodes Portfolio Manager, Rameez Sadikot.  Key times: Thoughts on Trump's '90-day pause': 1:00 How damaging could big China tariffs be? 2:20 Tariff implications for inflation and economic growth: 5:00 Is the market adequately pricing tariff implications? 8:20 Can Europe and China stocks benefit from US tariffs? 10:00 Latin American markets to watch: 10:50 Is the current stock market broadening sustainable? 11:30

Antipodes portfolio manager, James Rodda, joins Alison Savas after returning from three bell-weather conferences across the US covering tech, media and telcos and consumer.

In episode, Alison Savas interviews Antipodes' senior trader, Steve Sevier.  Key Times: Steve reflects on trading through the mid 2000s: 2:00 A trader's day: 4:00 The evolution of stock markets - who can move markets today? 6:40 The implications of trend chasing, increased retail participation, and shortened investment horizons: 10:00 What can change market momentum? 13:30 The big dislocations in markets in 2025: 16:00 Are investors on the cusp of a rotation away from US stock market exceptionalism? 20:00 The implications of President Trump on stock markets: 20:50 More about Antipodes: https://antipodes.com/

Antipodes CIO, Jacob Mitchell joins Investment Director, Alison Savas, to discuss Antipodes' portfolio positioning and the outlook for global equities. Jacob also discusses why investors should watch gold stocks in 2025, and challenges that tech giant Apple Inc. (NASDAQ: AAPL) is facing. Key Times: The Trump inauguration: what now for markets? 1:00 Stocks vs bonds: mixed messages? 3:50 The outlook for US equities in 2025: 8:00 Are we on the cusp of a change in global fiscal impulse? 12:30 Can Europe's valuation discount narrow? 17:30 Outlook for Chinese equities: 19:50 AI inflection point and big shifts in Central Bank gold buying: 22:50 The bear case for Apple Inc (NASDAQ: AAPL): 28:30 More about Antipodes Partners: https://antipodes.com/ Stock commentary is illustrative only, not a recommendation to buy, hold, or sell any security.

In this year-end episode for 2024, Alison Savas invites Antipodes' Sector Portfolio Managers to discuss their outlook for 2025. Each PM shares their insights on key sectors and stocks to watch in the new year, including a stock they believe will outperform and one they advise investors to steer clear of.   Key Times:   0:35 | Graham Hay - Hardware, Industrials & Commodities Portfolio Manager Stock to watch: Keysight Technologies, Inc. (NYSE: KEYS) Sector to avoid: Large cap technology stocks 8:45 | Nick Cameron - Healthcare Portfolio Manager Stock to watch: Alcon AG (SWX: ALC) Sector to avoid: Small to mid-cap medical device companies 16:15 | Max Shramchenko - Infrastructure Portfolio Manager Stock to watch: RWE AG (ETR: RWE) Sector to avoid: Conventional power generating assets in US 23:15 | James Rodda - Developed Markets, Technology, Media and Telecommunications Portfolio Manager Stock to watch: Alphabet Inc (NASDAQ: GOOG) Sector to avoid: Large cap technology stocks (ex Alphabet) 28:30 | John Stavliotis - Emerging Markets Portfolio Manager Stock to watch: DiDi Global Inc. (ADR: DIDIY) Sector to avoid: Indian Mid cap Universe   More about Antipodes Partners: https://antipodes.com/ Stock commentary is illustrative only, not a recommendation to buy, hold, or sell any security.